CLINICAL_TRIALS
research
· 2026-04-13
Clinical Trial Update: Fecal Microbiota Transplant vs Standard Treatment for Recurrent Non-Obstructive Cholangitis [Phase 2]
Summary
A Phase 2 trial comparing fecal microbiota transplant to standard treatment for recurrent acute cholangitis. The study is sponsored by Puerta de Hierro Universi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Puerta de Hierro University Hospital | Conditions: Cholangitis Acute, Recurrence | Phase 2 | Status: NOT_YET_RECRUITING